{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:59:55Z","timestamp":1772182795932,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T00:00:00Z","timestamp":1326153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029933","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T16:53:08Z","timestamp":1326214388000},"page":"e29933","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":92,"title":["Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: \u201cIn Vivo\u201d Evidence from FAP Mice Models"],"prefix":"10.1371","volume":"7","author":[{"given":"Nelson","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Saraiva","sequence":"additional","affiliation":[]},{"given":"Maria Ros\u00e1rio","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1172\/JCI111390","article-title":"Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).","volume":"74","author":"MJ Saraiva","year":"1984","journal-title":"J Clin Invest"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy.","volume":"36","author":"MD Benson","year":"2007","journal-title":"Muscle Nerve"},{"issue":"29","key":"ref3","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants.","volume":"276","author":"A Quintas","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/jmbi.2002.5441","article-title":"Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.","volume":"317","author":"I Cardoso","year":"2002","journal-title":"J Mol Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.","volume":"159","author":"MM Sousa","year":"2001","journal-title":"Am J Pathol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00795-005-0288-1","article-title":"Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).","volume":"38","author":"Y Ando","year":"2005","journal-title":"Med Mol Morphol"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402004647","article-title":"Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies.","volume":"4","author":"MJ Saraiva","year":"2002","journal-title":"Expert Rev Mol Med"},{"issue":"22","key":"ref8","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.febslet.2009.10.062","article-title":"Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.","volume":"583","author":"N Ferreira","year":"2009","journal-title":"FEBS Lett"},{"issue":"15","key":"ref9","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.febslet.2011.06.030","article-title":"Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation.","volume":"585","author":"N Ferreira","year":"2011","journal-title":"FEBS Lett"},{"issue":"29","key":"ref10","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1021\/bi1004409","article-title":"The crystal structure of the green tea polyphenol (\u2212)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site.","volume":"49","author":"M Miyata","year":"2010","journal-title":"Biochemistry"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.sbi.2009.12.009","article-title":"Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses.","volume":"20","author":"S Connelly","year":"2010","journal-title":"Curr Opin Struct Biol"},{"key":"ref12","first-page":"1497","article-title":"Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy.","volume":"150","author":"K Kohno","year":"1997","journal-title":"Am J Pathol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2008.04.001","article-title":"The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems.","volume":"31","author":"SD Santos","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","article-title":"Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.","volume":"161","author":"MM Sousa","year":"2002","journal-title":"Am J Pathol"},{"issue":"Pt 2","key":"ref15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20040011","article-title":"Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.","volume":"381","author":"MR Almeida","year":"2004","journal-title":"Biochem J"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/13.8.693","article-title":"Congo Red as a stain for fluorescence microscopy of amyloid.","volume":"13","author":"H Puchtler","year":"1965","journal-title":"J Histochem Cytochem"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF02976881","article-title":"Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice.","volume":"26","author":"EK Song","year":"2003","journal-title":"Arch Pharm Res"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.fct.2005.07.005","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity.","volume":"44","author":"RA Isbrucker","year":"2006","journal-title":"Food Chem Toxicol"},{"issue":"31","key":"ref19","doi-asserted-by":"crossref","first-page":"21998","DOI":"10.1074\/jbc.M602302200","article-title":"Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy.","volume":"281","author":"PF Teixeira","year":"2006","journal-title":"J Biol Chem"},{"issue":"11\u201312","key":"ref20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2119\/2007-00068.Macedo","article-title":"Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy.","volume":"13","author":"B Macedo","year":"2007","journal-title":"Mol Med"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","article-title":"Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.","volume":"92","author":"GA Tennent","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1096\/fj.04-2022fje","article-title":"Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy.","volume":"19","author":"MM Sousa","year":"2005","journal-title":"FASEB J"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.","volume":"15","author":"DE Ehrnhoefer","year":"2008","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/carcin\/19.10.1771","article-title":"Wide distribution of [3H](\u2212)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue.","volume":"19","author":"M Suganuma","year":"1998","journal-title":"Carcinogenesis"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1093\/jn\/133.12.4172","article-title":"Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice.","volume":"133","author":"JD Lambert","year":"2003","journal-title":"J Nutr"},{"issue":"17","key":"ref26","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.","volume":"27;107","author":"J Bieschke","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2B","key":"ref27","first-page":"747","article-title":"EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells.","volume":"24","author":"HS Kim","year":"2004","journal-title":"Anticancer Res"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/156800705774322076","article-title":"Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses.","volume":"4","author":"MR Almeida","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10048-003-0160-1","article-title":"Sulfite and base for the treatment of familial amyloidotic polyneuropathy: two additive approaches to stabilize the conformation of human amyloidogenic transthyretin.","volume":"5","author":"K Altland","year":"2004","journal-title":"Neurogenetics"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1096\/fj.05-4509com","article-title":"Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.","volume":"20","author":"I Cardoso","year":"2006","journal-title":"FASEB J"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","article-title":"Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy.","volume":"1782","author":"B Macedo","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phrs.2010.08.001","article-title":"Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model.","volume":"62","author":"B Macedo","year":"2010","journal-title":"Pharmacol Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined doxycycline\/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models.","volume":"8","author":"I Cardoso","year":"2010","journal-title":"J Transl Med"},{"issue":"9","key":"ref34","first-page":"3312","article-title":"Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.","volume":"9","author":"HH Chow","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"11\u201312","key":"ref35","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.nut.2009.09.021","article-title":"Bioavailability and catabolism of green tea flavan-3-ols in humans.","volume":"26","author":"D Del Rio","year":"2010","journal-title":"Nutrition"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2007-05-089243","article-title":"Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option?","volume":"110","author":"W Hunstein","year":"2007","journal-title":"Blood"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00392-010-0142-x","article-title":"Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis.","volume":"99","author":"D Mereles","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.3390\/ijms12095592","article-title":"Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?","volume":"12","author":"D Mereles","year":"2011","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jns.2008.05.014","article-title":"A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis.","volume":"272","author":"K Nakagawa","year":"2008","journal-title":"J Neurol Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0891-5849(96)00237-7","article-title":"Scavenging effects of tea catechins and their derivatives on 1, 1-diphenyl-2-picrylhydrazyl radical.","volume":"21","author":"F Nanjo","year":"1996","journal-title":"Free Radic Biol Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0005-2760(96)00122-1","article-title":"Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes.","volume":"1304","author":"Q Guo","year":"1996","journal-title":"Biochim Biophys Acta"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T05:18:37Z","timestamp":1561180717000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029933"}},"subtitle":[],"editor":[{"given":"Sergio T.","family":"Ferreira","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,1,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029933","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13524956.14900056","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,10]]}}}